Press release
July 22, 2026
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Tiziana Life Sciences Ltd (TLSA)
BOSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody,